Stock research
IMA ImageneBio Inc
Healthcare • Biotechnology
ImageneBio Inc (IMA) is a biotechnology company with therapies currently undergoing human trials. The firm concentrates on creating innovative medical treatments for a variety of immune-related and inflammatory...…
ImageneBio Inc (IMA) is a biotechnology company with therapies currently undergoing human trials. The firm concentrates on creating innovative medical treatments for a variety of immune-related and inflammatory diseases. A key component of their pipeline is IMG-007, a non-depleting anti-OX40 monoclonal antibody, which is now in Phase 2b clinical studies targeting atopic dermatitis.
1Y change
-64.25%
Range high
$15.75
Congress · 90d
0
Insiders · 90d
0
Public signal layer
Who is disclosing activity in IMA?
Price
Showing 1Y history. Source: FMP historical price full.
- Prev Close
- $5.75
- Day High
- $5.72
- Day Low
- $5.35
- 52w High
- $15.79
- 52w Low
- $3.94
- Volume
- 21,626
- Avg Volume
- Beta
- 0.76465327
* TTM/most recent where available
Company
- Ticker
- IMA
- Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- US
- CEO
- Kristin Yarema
- Employees
- 15
- Website
- www.inmagenebio.com
Key Metrics
- Market Cap
- 63.5M
- P/E
- P/B
- P/S
- EV/EBITDA
- ROE
- Net Margin
- Div Yield
- FCF/Share
* TTM/most recent where available
DCF Valuation
Standard DCF
Levered DCF
Market Price
DCF vs Price (30D window)
Price uses last 30 days; DCF line holds latest value across the window.DCF line = solid green (latest value repeated across window), Price = dashed blue (daily closes).